Gulf International Bank (UK)’s Charles River Laboratories CRL Stock Holding History

Gulf International Bank (UK)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,029	Closed	-$743K	–	631
2024 Q4	$743K	Hold	4,029	–	–	0.02%	529
2024 Q3	$793K	Sell	4,029 -250	-6%	-$52K	0.02%	529
2024 Q2	$883K	Hold	4,279	–	–	0.02%	506
2024 Q1	$1.16M	Buy	4,279 +33	+0.8%	+$7.88K	0.03%	467
2023 Q4	$1M	Sell	4,246 -489	-10%	-$96.2K	0.03%	486
2023 Q3	$927K	Sell	4,735 -401	-8%	-$82.3K	0.03%	511
2023 Q2	$1.08M	Sell	5,136 -1,532	-23%	-$305K	0.03%	499
2023 Q1	$1.34M	Sell	6,668 -1,466	-18%	-$332K	0.03%	506
2022 Q4	$1.77M	Hold	8,134	–	–	0.03%	487
2022 Q3	$1.6M	Hold	8,134	–	–	0.03%	496
2022 Q2	$1.78M	Hold	8,134	–	–	0.03%	494
2022 Q1	$2.31M	Hold	8,134	–	–	0.03%	456
2021 Q4	$3.06M	Sell	8,134 -1,700	-17%	-$660K	0.04%	410
2021 Q3	$4.06M	Buy	9,834 +1,589	+19%	+$660K	0.05%	375
2021 Q2	$3.05M	Buy	+8,245	New	+$2.75M	0.04%	466

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gulf International Bank (UK)'s CRL Position: Q1 2025 in Review

Gulf International Bank (UK) sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 4,029 shares — an estimated $743K sold.

Gulf International Bank (UK) first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $4.06M in Q3 2021. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

Gulf International Bank (UK) reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
Gulf International Bank (UK) sold 4,029 Charles River Laboratories shares in Q1 2025, an estimated $743K.
Gulf International Bank (UK) first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
Gulf International Bank (UK)'s Charles River Laboratories position peaked at $4.06M in Q3 2021.
560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2025, filed 13 May 2025.